Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

Abstract Background There is ongoing controversy regarding abacavir use in the treatment of HIV infection and the risk of subsequent development of cardiovascular disease. It is unclear how the risk varies as exposure accumulates. Methods Using an administrative health-plan dataset, risk of cardiova...

Full description

Bibliographic Details
Main Authors: Kunchok Dorjee, Sanjiv M. Baxi, Arthur L. Reingold, Alan Hubbard
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Infectious Diseases
Subjects:
HIV
Online Access:http://link.springer.com/article/10.1186/s12879-017-2808-8